Organobalance GmbH
Records under this name other than patents Organobalance GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,846,711 | Novel Lactobacillus Strains and Uses Thereof now held by Novozymes A/S In force · High confidence | In force | High confidence | |
| US 9,220,672 | Peptide for Use in the Treatment of Skin Conditions now held by Novozymes A/S In force · High confidence | In force | High confidence | |
| US 11,053,474 | Novel Lactobacillus Strains and the Uses Thereof now held by Novozymes A/S In force · High confidence | In force | High confidence | |
| US 7,608,421 | Method for the Production of 7-Dehydrocholesterol And/Or the Biosynthetic Intermediate Orsubsequent Products Thereof in Transgenic Organisms now held by Novozymes A/S Term ended Term ended Nov 8, 2023 · High confidence | Term ended | Term ended Nov 8, 2023 | High confidence |
| US 9,051,587 | Yeast Cell for the Production of Terpenes and Uses Thereof now held by Novozymes A/S Lapsed on the fee record Ended Jun 9, 2023 · High confidence | Lapsed on the fee record | Ended Jun 9, 2023 | High confidence |
| US 8,841,114 | Genetically Modified Organism for the Production of Lipids now held by Novozymes A/S Lapsed on the fee record Ended Sep 23, 2022 · High confidence | Lapsed on the fee record | Ended Sep 23, 2022 | High confidence |
| US 10,011,838 | Yeast Strain and Microbial Method for Production of Pentacyclic Triterpenes And/Or Triterpenoids now held by Novozymes A/S Lapsed on the fee record Ended Jul 3, 2022 · High confidence | Lapsed on the fee record | Ended Jul 3, 2022 | High confidence |
| US 9,598,710 | Genetically Modified Organism for the Production of Lipids now held by Novozymes A/S Lapsed on the fee record Ended Mar 21, 2021 · High confidence | Lapsed on the fee record | Ended Mar 21, 2021 | High confidence |
| US 7,556,937 | Method for Producing ERGOSTA-5,7-Dienol And/Or Biosynthetic Intermediate And/Or Secondary Products Thereof in Transgenic Organisms Lapsed on the fee record Ended Jul 7, 2013 · High confidence | Lapsed on the fee record | Ended Jul 7, 2013 | High confidence |
| 10/665,449 | Process for the production of ergosterol and its intermediate products using recombinant yeasts now held by Bayer Schering Pharma Aktiengesellschaft Abandoned Abandoned Jul 21, 2010 | Abandoned | Abandoned Jul 21, 2010 |